Nortadalafil
CAS No. 171596-36-4
Nortadalafil ( Demethyl Tadalafil )
Catalog No. M20552 CAS No. 171596-36-4
Nortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 40 | In Stock |
|
5MG | 65 | In Stock |
|
10MG | 102 | In Stock |
|
25MG | 192 | In Stock |
|
50MG | 335 | In Stock |
|
100MG | 537 | In Stock |
|
200MG | 762 | In Stock |
|
500MG | 1134 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNortadalafil
-
NoteResearch use only not for human use.
-
Brief DescriptionNortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
-
DescriptionNortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
-
SynonymsDemethyl Tadalafil
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number171596-36-4
-
Formula Weight375.38
-
Molecular FormulaC21H16N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (133.20 mM)
-
SMILESO=C1CNC(=O)[C@H]2Cc3c([nH]c4ccccc34)[C@H](N12)c1ccc2OCOc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Takahiro R Nakamura S Kohno H et al. Contribution of CYP3A Isoforms to Dealkylation of PDE5 Inhibitors: A Comparison between Sildenafil N-Demethylation and Tadalafil Demethylenation[J]. Biological & Pharmaceutical Bulletin 2015 38(1):58-65.
molnova catalog
related products
-
Piclamilast
Piclamilast is a PDE4 inhibitor.
-
LJI308
LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.
-
Tofimilast
Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively.